+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lymphoma"

Refractory Follicular Lymphoma Diagnostics - Global Strategic Business Report - Product Thumbnail Image

Refractory Follicular Lymphoma Diagnostics - Global Strategic Business Report

  • Report
  • November 2026
  • 369 Pages
  • Global
From
BCL-2 b-Cell Lymphoma 2 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

BCL-2 b-Cell Lymphoma 2 Inhibitors - Global Strategic Business Report

  • Report
  • November 2026
  • 204 Pages
  • Global
From
T-Xell Lymphoma - Global Strategic Business Report - Product Thumbnail Image

T-Xell Lymphoma - Global Strategic Business Report

  • Report
  • November 2026
  • 281 Pages
  • Global
From
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2036 - Product Thumbnail Image

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Target Population, Competitive Landscape, and Market Forecast - 2036

  • Report
  • July 2026
  • 130 Pages
  • Global
From
Hodgkin's Lymphoma Market Insight, Epidemiology and Market Forecast - 2036 - Product Thumbnail Image

Hodgkin's Lymphoma Market Insight, Epidemiology and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Follicular Lymphoma - Market Insight, Epidemiology, and Market Forecast - 2036 - Product Thumbnail Image

Follicular Lymphoma - Market Insight, Epidemiology, and Market Forecast - 2036

  • Report
  • February 2026
  • 200 Pages
  • Global
From
Follicular Lymphoma Pipeline Analysis Report 2026 - Product Thumbnail Image

Follicular Lymphoma Pipeline Analysis Report 2026

  • Report
  • May 2026
  • 150 Pages
  • Global
From
Small Lymphocytic Lymphoma Drug Pipeline Analysis Report 2026 - Product Thumbnail Image

Small Lymphocytic Lymphoma Drug Pipeline Analysis Report 2026

  • Drug Pipelines
  • May 2026
  • 150 Pages
  • Global
From
Global Diffuse Large B-Cell Lymphoma (Dlbcl) Therapeutics Market 2026-2030 - Product Thumbnail Image

Global Diffuse Large B-Cell Lymphoma (Dlbcl) Therapeutics Market 2026-2030

  • Report
  • November 2026
  • 299 Pages
  • Global
From
Global Hodgkin Lymphoma Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Global Hodgkin Lymphoma Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • July 2026
  • 110 Pages
  • Global
From
Adult T-Cell Leukemia/Lymphoma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Adult T-Cell Leukemia/Lymphoma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • February 2026
  • 150 Pages
  • Global
From
Lymphoma Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Type, Type of Therapy, Mode, End User - Product Thumbnail Image

Lymphoma Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Disease Type, Type of Therapy, Mode, End User

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Hodgkin Lymphoma Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type, Stage of Disease, Patient Age Group, Route of Administration - Product Thumbnail Image

Hodgkin Lymphoma Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis by Treatment Type, Stage of Disease, Patient Age Group, Route of Administration

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Market Outlook 2026-2034: Market Share, and Growth Analysis - Product Thumbnail Image

Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Market Outlook 2026-2034: Market Share, and Growth Analysis

  • Report
  • August 2026
  • 160 Pages
  • Global
From
Primary CNS Lymphoma (PCNSL): Market View - Product Thumbnail Image

Primary CNS Lymphoma (PCNSL): Market View

  • Report
  • March 2026
  • 106 Pages
  • Global
From
Oncology Collaboration and Licensing Deals 2021-2026 - Product Thumbnail Image

Oncology Collaboration and Licensing Deals 2021-2026

  • Report
  • October 2026
  • 1400 Pages
  • Global
From
Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2026 - Product Thumbnail Image

Precision Medicine in Oncology Collaboration and Licensing Deals 2016-2026

  • Report
  • May 2026
  • 500 Pages
  • Global
From
Targeted Protein Degradation in Oncology Market Report: 2027-2031 Forecast, Strategic Opportunities by Modality, Indication, Target, E3 Ligase, Product and Country - Strategic Analysis of 12 Companies - Product Thumbnail Image

Targeted Protein Degradation in Oncology Market Report: 2027-2031 Forecast, Strategic Opportunities by Modality, Indication, Target, E3 Ligase, Product and Country - Strategic Analysis of 12 Companies

  • Report
  • October 2026
  • 161 Pages
  • Global
From
Oncology Gene Therapy Market Report: 2027-2031 Forecast, Strategic Opportunities by Approach, Vector, Indication, Product, Route of Administration and Country - Strategic Analysis of 15 Companies - Product Thumbnail Image

Oncology Gene Therapy Market Report: 2027-2031 Forecast, Strategic Opportunities by Approach, Vector, Indication, Product, Route of Administration and Country - Strategic Analysis of 15 Companies

  • Report
  • October 2026
  • 171 Pages
  • Global
From
B-cell Inhibitors Market for Non-Oncology Diseases: Industry Trends and Global Forecasts, Till 2035 - Distribution by Stage of Development, Indication and Key Geographies - Product Thumbnail Image

B-cell Inhibitors Market for Non-Oncology Diseases: Industry Trends and Global Forecasts, Till 2035 - Distribution by Stage of Development, Indication and Key Geographies

  • Report
  • December 2025
  • 402 Pages
  • Global
From
Loading Indicator

Lymphoma is a type of hematological malignancy that originates in the lymphatic system. It is characterized by the uncontrolled growth of lymphocytes, a type of white blood cell. Lymphomas can be either Hodgkin's or non-Hodgkin's, and can be either indolent or aggressive. Treatment options for lymphoma include chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. The lymphoma market is a subset of the larger hematology market, which includes treatments for a variety of blood-related diseases. The lymphoma market is driven by the increasing prevalence of the disease, as well as the development of new treatments. Companies in the lymphoma market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Celgene, Gilead Sciences, Novartis, and Pfizer. Show Less Read more